Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia
- PMID: 11810087
- DOI: 10.1067/mob.2002.120080
Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia
Abstract
Objective: The current literature emphasizes increased risk of adverse outcomes in the presence of proteinuria and hypertension. The objective of this study was to compare the frequency of adverse fetal outcomes in women who developed hypertensive disorders with or without proteinuria.
Study design: The study design was a secondary analysis of data from women who had preeclampsia in a previous pregnancy (n = 598) who were enrolled in a multicenter trial of aspirin for the prevention of preeclampsia. The women had no history of chronic hypertension or renal disease and were normotensive at study inclusion. The maternal and perinatal outcome variables assessed were preterm delivery at <37 and <35 weeks of gestation, rate of small-for-gestational-age infants, and abruptio placenta. Data were analyzed by using the chi-square test, and women who remained normotensive or who had mild gestational hypertension were considered as a single group because they had similar outcomes.
Results: As compared to mild preeclampsia, women who developed severe gestational hypertension (without proteinuria) had higher rates of both preterm delivery at <37 weeks of gestation and small-for-gestational-age infants. In addition, when compared to women with mild preeclampsia, for women with severe gestational hypertension, gestational age and birth weight were significantly lower at delivery (P <.003 for both age and birth weight). Moreover, women who developed severe gestational hypertension had higher rates of preterm delivery at <37 weeks of gestation (54.2% vs 17.8%, P =.001) and at <35 weeks of gestation (25.0% vs 8.4%, P =.0161), and delivery of small-for-gestational-age infants (20.8% vs 6.5%, P =.024) when compared to women who remained normotensive or those who developed mild gestational hypertension. There were no statistically significant differences in perinatal outcomes between the normotensive/mild gestational hypertension and the mild preeclampsia groups. Overall, women who had severe gestational hypertension had increased rates of preterm delivery and delivery of small-for-gestational-age infants than women with mild gestational hypertension or mild preeclampsia. In the presence of severe hypertension, proteinuria did not increase the rates of preterm delivery or delivery of small-for-gestational-age infants.
Conclusions: In women who have gestational hypertension or preeclampsia, increased rates of preterm delivery and delivery of small-for-gestational-age infants are present only in those with severe hypertension. In these women, the presence of proteinuria does not influence perinatal outcome.
Similar articles
-
Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.Am J Obstet Gynecol. 2000 Apr;182(4):938-42. doi: 10.1016/s0002-9378(00)70350-4. Am J Obstet Gynecol. 2000. PMID: 10764477
-
Rate of Gestational Diabetes Mellitus and Pregnancy Outcomes in Patients with Chronic Hypertension.Am J Perinatol. 2016 Jul;33(8):745-50. doi: 10.1055/s-0036-1571318. Epub 2016 Feb 18. Am J Perinatol. 2016. PMID: 26890438 Clinical Trial.
-
Mild gestational hypertension remote from term: progression and outcome.Am J Obstet Gynecol. 2001 Apr;184(5):979-83. doi: 10.1067/mob.2001.112905. Am J Obstet Gynecol. 2001. PMID: 11303208
-
Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?Am J Obstet Gynecol. 2020 May;222(5):437-450. doi: 10.1016/j.ajog.2019.08.047. Epub 2019 Sep 5. Am J Obstet Gynecol. 2020. PMID: 31494125
-
Maternal and Perinatal Outcomes of White Coat Hypertension During Pregnancy: A Systematic Review and Meta-Analysis.Hypertension. 2020 Jul;76(1):157-166. doi: 10.1161/HYPERTENSIONAHA.119.14627. Epub 2020 May 26. Hypertension. 2020. PMID: 32450741
Cited by
-
Placental Growth Factor (PlGF)- Based Biomarker Testing to Help Diagnose Pre-eclampsia in People With Suspected Pre-eclampsia: A Health Technology Assessment.Ont Health Technol Assess Ser. 2023 May 17;23(3):1-146. eCollection 2023. Ont Health Technol Assess Ser. 2023. PMID: 37284279 Free PMC article.
-
Impact of pregnancy-induced hypertension on stillbirth and neonatal mortality.Epidemiology. 2010 Jan;21(1):118-23. doi: 10.1097/EDE.0b013e3181c297af. Epidemiology. 2010. PMID: 20010214 Free PMC article.
-
Hypertensive disorders of pregnancy.J Prenat Med. 2009 Jan;3(1):1-5. J Prenat Med. 2009. PMID: 22439030 Free PMC article.
-
Effect of Placenta Previa on Preeclampsia.PLoS One. 2016 Jan 5;11(1):e0146126. doi: 10.1371/journal.pone.0146126. eCollection 2016. PLoS One. 2016. PMID: 26731265 Free PMC article.
-
Maternal diet, nutritional status and infant birth weight in Malaysia: a scoping review.BMC Pregnancy Childbirth. 2022 Apr 6;22(1):294. doi: 10.1186/s12884-022-04616-z. BMC Pregnancy Childbirth. 2022. PMID: 35387600 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials